Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Feb 2024 for UpHealth, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Mark Guinan: trading record in brief
This profile gathers the share dealings of Mark Guinan across 3 companies, led by Quest Diagnostics Inc, Myovant Sciences Ltd. and UpHealth, Inc. Over a trading history stretching from 23 February 2022 to 31 January 2024, the count stands at 7 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 2 February 2024, reports a share grant in UpHealth, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Guinan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
100,000 shares0Common StockSEC:0001062993-24-001879:0
3,673 sharesCommon SharesSEC:0001209191-23-017717:0
60,606 shares0Common StockSEC:0001062993-22-024180:0
9,859 shares0Common SharesSEC:0001209191-22-054816:0
20,780 shares@ US$130.0992.8% of flowCommon StockSEC:0001022079-22-000058:0
2,251 shares0Common StockSEC:0001022079-22-000033:0
1,673 shares@ US$130.097.2% of flowCommon StockSEC:0001022079-22-000017:0
7 of 7 declarations
